Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 9043-9048
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.9043
Table 1 Characteristics of the study population n (%)
Gender, males71/145 (49)
Age
(min, max)(8, 85)
mean (SD)50.1 (19.2)
Main indication for CE1n = 1502
Overt obscure bleeding58 (38.7)
Occult obscure bleeding23 (15.3)
Anemia19 (12.7)
Malabsorption18 (12.0)
Abnormal SB follow through9 (6.0)
Abdominal pain7 (4.7)
Celiac disease5 (3.3)
Neuroendocrine tumor3 (2.0)
Peutz-Jeghers syndrome2 (1.3)
Diarrhea2 (1.3)
Crohn’s disease2 (1.3)
Polyposis syndrome2 (1.3)
Table 2 Results of 150 capsule endoscopy examinations n (%)
Findingsn = 150
Significant findings
Angioectasias25 (16.7)
Mucosal breaks20 (13.3)
Tumor or polyp(s) ≥ 10 mm15 (10.0)
Diverticula14 (9.3)
Celiac disease5 (3.3)
Active bleeding with no visible origin3 (2.0)
Insignificant findings
Erythema or red spots15 (10.0)
White spots13 (8.7)
Other7 (4.7)
Modeling of the bowel wall2 (1.3)
Normal29 (19.3)
Non-diagnostic2 (1.3)
Table 3 Characteristics of patients with tumor or polyp(s) ≥ 10 mm detected on capsule endoscopy and the results of follow-up
No.Age (yr)SexIndication for CEBleeding on CECE reached the colonDBE resultSurgery resultNeoplasm
121FPJS-NADysplastic Peutz-Jeghers polypyes
225MPolyposis--NADysplastic Peutz-Jeghers polypyes
330MOvert OGIB--NAMeckel's diverticulumno
436FOccult OGIB-NASB adenocarcinomayes
537FOccult OGIB--Dysplastic Peutz-Jeghers polyp in jejunumNot operated onyes
647MMalabsorptionNAUnknown but benignunknown
750MAbnormal SBFT-NANot operated onunknown
853MOvert OGIB-NAGISTyes
953MPJS-NADysplastic Peutz-Jeghers polypyes
1056MAnemia, disseminated melanoma malignum--NAMelanoma malignum metastasisyes
1159FOvert OGIBSubmucosal tumorVenous malformationno
1260FOvert OGIB-NAGISTyes
1364FOvert OGIB-NASB adenocarcinomayes
1468FOccult OGIB--NAInflammatory tumorno
1568FOvert OGIB-NAGISTyes